Status:
UNKNOWN
Transcriptomic Signatures in Gastric Adenocarcinoma
Lead Sponsor:
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Conditions:
Gastric Adenocarcinoma
Eligibility:
All Genders
18-80 years
Brief Summary
Gastric Adenocarcinoma (GAC) accounting for the major percentage of all stomach malignancies is associated with a poor overall survival of 25-30% despite the advancement in treatment strategies. Sever...
Detailed Description
This study on Gastric adenocarcinoma is retrospective as well as prospective that will be conducted at SGPGIMS, Lucknow, India. Patients undergoing gastric resection at the department of surgical gast...
Eligibility Criteria
Inclusion
- Patients with origin of tumor in distal part of stomach
- Patients who underwent Total or partial Gastrectomy after Biopsy examination
- Availability of follow up in Radiotherapy or Gastro department
- Availability of FFPE gastrectomy specimen tissue of selected cases in Histopathology
Exclusion
- Patients with origin of tumor in proximal part of stomach
- Patients with only biopsy available
- Patients whose follow-up is not available
- Unavailability of FFPE tissue blocks
Key Trial Info
Start Date :
August 6 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 6 2025
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT05319392
Start Date
August 6 2021
End Date
October 6 2025
Last Update
April 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Lucknow, Uttar Pradesh, India, 226014